XML 148 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 997 $ 401
Short-term investments 11 8
Accounts receivable, net 1,093 1,279
Inventories 1,187 1,450
Prepaid expenses and assets held for sale 67 261
Total current assets 3,355 3,399
Property, plant and equipment, net 2,264 2,370
Intangible assets, net 1,264 1,303
Other non-current assets 561 570
Total assets 7,444 7,642
Current liabilities:    
Short-term borrowings 44 448
Accounts payable 604 778
Accrued liabilities and liabilities held for sale 633 546
Total current liabilities 1,281 1,772
Long-term debt 1,787 1,740
Other non-current liabilities 486 480
Total liabilities 3,554 3,992
Share-based payments subject to redemption 60 55
Redeemable non-controlling interests 7 43
Ingredion stockholders’ equity:    
Preferred stock — authorized 25.0 shares — $0.01 par value, none issued 0 0
Common stock — authorized 200.0 shares — $0.01 par value, 77.8 issued at December 31, 2024 and 2023 1 1
Additional paid-in capital 1,152 1,146
Less: Treasury stock (common stock: 13.3 and 12.6 shares at December 31, 2024 and 2023) at cost (1,355) (1,207)
Accumulated other comprehensive loss (1,086) (1,056)
Retained earnings 5,092 4,654
Total Ingredion stockholders’ equity 3,804 3,538
Non-redeemable non-controlling interests 19 14
Total stockholders’ equity 3,823 3,552
Total liabilities and stockholders’ equity $ 7,444 $ 7,642